美股市場個股詳情
BPMC Blueprint Medicines
- 93.000
- +2.270+2.50%
收盤價 04/26 16:00 (美東)
- 94.990
- +1.990+2.14%
盤後 19:13 (美東)
58.42億總市值-11111市盈率TTM
94.980最高價90.470最低價72.60萬股成交量92.760今開90.730昨收6774.42萬成交額1.17%換手率虧損市盈率(靜)6281.49萬總股本101.00052周最高44.73市淨率57.78億流通值43.89052周最低--股息TTM6213.05萬流通股125.610歷史最高--股息率TTM4.97%振幅13.040歷史最低93.316平均價1股每手
關於Blueprint Medicines公司
藍圖醫藥公司是一家生物製藥公司。它專注於改善由異常激酶激活引起的疾病患者的生活。該公司開發了針對癌症和罕見遺傳病的小分子藥物管線。其候選藥物包括用於治療系統性肥大細胞增多症的AYVAKIT，BLU-808，一種治療肥大細胞疾病（包括慢性蕁麻疹、睡眠中斷和其他相關疾病）的潛在藥物。該公司還有其他藥物正在研發中，例如用於治療乳腺癌的BLU-956、BLU-222。
公司介紹
公司代碼BPMC
公司名稱Blueprint Medicines
上市日期2015/04/30
發行價格18.00
成立日期2008
CEOMs. Kathryn Haviland
所屬市場納斯達克
員工數量655
證券類型海外普通股
年結日12-31
公司地址45 Sidney Street
城市Cambridge
省份麻塞諸塞州
國家美國
郵編02139
電話1-617-374-7580
董事高管
- 姓名
- 職務
- 年薪
- Kathryn Haviland
- Director, President and Chief Executive Officer
- 643.20萬
- Michael Landsittel, M.B.A.
- Chief Financial Officer
- 219.48萬
- Dr. Becker Hewes, M.D.
- Chief Medical Officer
- --
- Tracey L. McCain, Esq.
- Chief Legal and Compliance Officer
- 234.64萬
- Debra Durso-Bumpus
- Chief People Officer
- --
- Christina Rossi, M.B.A.
- Chief Operating Officer
- 280.62萬
- Dr. Percy H. Carter, M.B.A.,PhD
- Chief Scientific Officer
- 229.98萬
- Dr. Philina Lee, PhD
- Chief Commercial Officer
- --
- Dr. Christopher K. Murray, PhD
- Chief Technical Operations and Quality Officer
- --
- Ariel Hurley
- Senior Vice President, Finance and Principal Accounting Officer
- --
- Jeffrey W. Albers, J.D.
- Chairman of the Board
- 52.61萬
- Dr. Fouad Namouni, M.D.
- President, Research and Development
- 280.18萬
- Alexis A. Borisy, A.M.
- Director
- 39.73萬
- Daniella Beckman
- Independent Director
- 42.23萬
- Dr. John Tsai, M.D.
- Independent Director
- 76.98萬
- Dr. Nicholas Lydon, F.R.S.,PhD
- Independent Director
- 41.73萬
- Dr. Lynn Seely,M.D.
- Lead Independent Director
- 45.23萬
- Habib Joseph Dable
- Independent Director
- 41.23萬
- Dr. Mark Alan Goldberg, M.D.
- Independent Director
- 41.93萬
- Lonnel Coats
- Independent Director
- 41.93萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
